Potential drug interaction with opioid agonist in the setting of chronic low-dose opioid antagonist use

被引：7

作者：

Leonard, James B. ^{[1
]}

Nair, Vidya ^{[1
]}

Diaz, Christopher J. ^{[1
]}

Penoyar, Jonathan B. ^{[1
]}

Goode, Penelope A. ^{[1
]}

机构：

[1] Providence St Peter Hosp, Serv Pharm, 413 Lilly Rd NE, Olympia, WA 98506 USA

来源：

AMERICAN JOURNAL OF EMERGENCY MEDICINE | 2017年 / 35卷 / 08期

关键词：

NALTREXONE; FIBROMYALGIA;

D O I：

10.1016/j.ajem.2017.04.012

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

Low dose naltrexone (LDN) has been evaluated in several small studies for the treatment of inflammatory conditions. It is thought to work through modulation of inflammatory mediators and upregulation of endogenous opioid receptors. This may hypersensitize patients to exogenous opioids. Drug-drug interaction screening tools built into electronic health records and other services identify the interaction as risk of opioid withdrawal rather than hypersensitivity. We present a case of a drug-drug interaction in a patient who was receiving LDN treatment of multiple sclerosis. The patient received a single dose of oxycodone 5 mg that resulted in obtundation unresponsive to painful stimuli necessitating the administration of naloxone boluses and infusion along with admission to the intensive care unit for 1 night. The patient responded well to naloxone therapy. He was discharged in satisfactory condition. (C) 2017 Elsevier Inc. All rights reserved.

引用

页码：1209.e3 / 1209.e4

页数：2

共 8 条

[1]

Burns LH, 2005, RECENT DEV PAIN RES, V661, P115

[2] Pilot Trial of Low-Dose Naltrexone and Quality of Life in Multiple Sclerosis [J].

Cree, Bruce A. C. ;

Kornyeyeva, Elena ;

Goodin, Douglas S. .

ANNALS OF NEUROLOGY, 2010, 68 (02) :145-150

[3] PARADOXICAL ANALGESIA INDUCED BY NALOXONE AND NALTREXONE [J].

GREELEY, JD ;

LE, AD ;

POULOS, CX ;

CAPPELL, H .

PSYCHOPHARMACOLOGY, 1988, 96 (01) :36-39

[4] Proposal for a new tool to evaluate drug interaction cases [J].

Horn, John R. ;

Hansten, Philip D. ;

Chan, Lingtak-Neander .

ANNALS OF PHARMACOTHERAPY, 2007, 41 (04) :674-680

[5]

TEMPEL A, 1985, J PHARMACOL EXP THER, V232, P439

[6] The use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic pain [J].

Younger, Jarred ;

Parkitny, Luke ;

McLain, David .

CLINICAL RHEUMATOLOGY, 2014, 33 (04) :451-459

[7] Low-Dose Naltrexone for the Treatment of Fibromyalgia [J].

Younger, Jarred ;

Noor, Noorulain ;

Mccue, Rebecca ;

Mackey, Sean .

ARTHRITIS AND RHEUMATISM, 2013, 65 (02) :529-538

[8] Fibromyalgia Symptoms Are Reduced by Low-Dose Naltrexone: A Pilot Study [J].

Younger, Jarred ;

Mackey, Sean .

PAIN MEDICINE, 2009, 10 (04) :663-672

← 1 →